Prospective Study of Different Biological Tests (Multiplate, ROTEM) in a Cohort of Patients Followed for Essential Thrombocytemia (ET) (THETE)

Civil Hospices of Lyon

Status: Completed

Conditions: Thrombocythemia Essential

Treatments: Biological: biological tests of haemostasis at each consultation (Multiplate, ROTEM, VASP)

Study type: Interventional

Funder types: Other

Identifiers

NCT03212053

69HCL17_0091

2017-A00737-46 (Other Identifier)

Details and patient eligibility

About

There is no prospective study published on the Essential Thrombocythemia and the correlation between this specific disease, its complications and the biological variations observed.

The aim of this study is to demonstrate a correlation between biological tests of haemostasis, as Multiplate analyser and thromboelastometry (ROTEM) and the occurrence of clinical complications, thrombosis and/or haemorrhage, in order to determine if this biological tests could be biological prognostic factors

Enrollment: 51 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult aged more than 18 years old
• Patient followed in consultation for an Essential Thrombocythemia at diagnosis or during the follow-up
• Collection of the informed consent
• Patient affiliated to Social Security

Exclusion criteria

• Patients aged less than 18 years old
• Refusal of signature of the informed consent
• Patients under guardianship

Trial design

Primary purpose: Screening

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

51 participants in 1 patient group

Patients with Essential Thrombocythemia

Other group

Description:

patients who come in consultation at diagnosis or during the follow-up for an Essential Thrombocythemia. They will have biological tests of haemostasis at each consultation (Multiplate, ROTEM, VASP)

Treatment:

Biological: biological tests of haemostasis at each consultation (Multiplate, ROTEM, VASP)